A collaboration between GE Healthcare and Imeka could help researchers and clinicians quickly obtain highly localized views of white matter, which can yield valuable insights into the impact of central nervous system diseases and disorders.
Three reasons why Medtronic's three-year renal denervation data is a really big deal.
FDA approved Abbott's Aveir VR leadless pacemaker. Will Boston Scientific's Empower MPS be next?
Bioventus said it has exercised its call option to acquire CartiHeal for about $315 million, with an additional approximately $135 million payable contingent upon the achievement of $100 million in trailing 12 month sales.
The Lexington, MA-based company said the study aims to examine the effect of Revita on improving glycemic control and preventing the need for insulin therapy.
Quickly catch up on the latest medtech news from Medtronic, Embecta, Masimo, and others.